
Boy, am I overdue for an update! More than 3 months have gone by since the Shands bad news... For those that haven't been updated by me personally, I apologize. I know many of my old friends and distant relatives depended on the blog for updates. The Shands experience didn't cause me to give up the fight, but the desire to give constant updates on the blog was squashed. But now I'm back. Here's a full and lengthy update...
Shands Says "No", MD Anderson Says "Yes"After Shands decided not to help me, I found out that one of the best head and neck surgeon's from Houston had recently relocated to Orlando and had a lot of experience with my specific cancer. I was able to get a referal from Dr Bibliowics to see him.
Melinda and I went as soon as possible to see Dr. Shellenberger at MD Anderson. Although his opinion after reviewing my case was that the previous doctors went about treatment in a way that left me with few current options, he agreed without question that he would take me as a patient and would "leave no stone left unturned" trying. We were very impressed with his attitude and willingness to help, unlike the doctors at Shands.
We then went on a roller coaster ride of changing ideas and opinions about how bad or good things were and how to approach treatment. I'm not resentful of this experience, because they were really trying hard to do the very best thing for me. And although it was difficult to go through it, I felt like we were in the best of care.
At first, it was viewed that the tumor wasn't around the carotid artery or at the skull base and that surgery could and should be done right away. Then it was determined that the cancer was dead (not "viable") and that surgery should wait until it returned. After doing a checkup with a fine needle aspiration, we found that the cancer returned. Then a new CT Scan shouwed that maybe the tumor was in fact around the carotid artery. With cancer back, surgery was inevitable...with it around the carotid, it was going to be very high risk. But we started moving towards that event, probably about three or four weeks ago.
Before I go on with the current update, let me introduce "my team" to you. The three key players are Dr. Shellenberger, Dr. Mañon, and Dr. Tseng. Here are their bios from the MD Anderson site. All are very experienced and I'm comfortable with the level of experience, expertise and humanity of all three.
Thomas D. Shellenberger, DMD, MD ___________________________________________________________
Dr. Thomas Shellenberger, head and neck surgeon, is a member of the Thoracic/Head & Neck Specialty Section at M. D. Anderson Cancer Center Orlando. He holds certification from the American Board of Surgery.
Dr. Shellenberger comes to M. D. Anderson – Orlando from The University of Texas M. D. Anderson Cancer Center in Houston where he recently completed a clinical and research fellowship in Head and Neck Surgical Oncology. He also completed the Physician-Scientist Training Program in the Graduate School of Biomedical Sciences of University of Texas at Houston. Additionally, Dr. Shellenberger fulfilled fellowships in oral and maxillofacial tumor and reconstructive surgery and in hyperbaric medicine and problem wounds at Jackson Memorial Medical Center at the University of Miami.
He completed his internship and residencies in oral and maxillofacial surgery and general surgery at Jackson Memorial Medical Center. At Jackson Memorial he served as the chief resident in oral and maxillofacial surgery and in general surgery.
Dr. Shellenberger holds doctorates in medicine from the University of Miami and in dental medicine from the University of Pittsburgh.
Dr. Shellenberger has received numerous awards including the Young Investigator Award from the American Society of Clinical Oncology, 1st place winner of the Bristol Myers Squibb Award in Clinical/Translational Research from the University of Texas M. D. Anderson Cancer Center and the Byers Award from the American Head and Neck Society.
He has published original articles in several peer-reviewed journals and authored chapters in text books of head and neck surgery. His translational research interests include angiogenesis, invasion and metastasis of squamous carcinoma. His clinical research interests include complicated thyroid cancer and sarcoma of the head and neck.
Dr. Shellenberger is a member of the American College of Surgeons, American Head and Neck Society, American Society of Clinical Oncology, American Association of Cancer Research.
Rafael Mañon, MD __________________________________________________________________

Dr. Mañon, whose specialty is thoracic, head and neck cancers and gynecologic oncology, is a board-certified radiation oncologist with M. D. Anderson Cancer Center Orlando.
Mañon completed a residency in radiation oncology at the University of Wisconsin (UW), an internship in internal medicine at Jackson Memorial Hospital in Miami and earned his medical degree from the University of Florida. AT UW, he served as the chief resident of radiation oncology during his final year and as an instructor in radiotherapy technology.
Mañon brings a wealth of experience in Helical Tomotherapy to M. D. Anderson – Orlando. Through the University of Wisconsin, where tomotherapy was created, he is researching and developing more aggressive treatments for cancer, with the aim of improving cancer cure rates while maintaining a clinically acceptable level of side effects.
Fluent in Spanish and English, Mañon received the Outstanding Achievement in Science, Engineering and Mathematics Award from the Office of Naval Research. He holds memberships in many professional societies including the American Society of Clinical Oncology, American Society for Therapeutic Radiology and Oncology, American Brachytherapy Society and the Association of Residents in Radiation Oncology. He has made presentations at several national meetings of these societies.
Additionally, Mañon has published several peer-reviewed articles in medical journals including the Journal of Clinical Oncology, Radiotherapy and Oncology and International Journal of Radiation Oncology Biology and Physics.
Jennifer E. Tseng, MD__________________________________________________________________

Jennifer E. Tseng, MD Dr. Tseng is the Thoracic and Head & Neck Cancer Specialty Section leader and the associate director for clinical research for Medical Oncology at M. D. Anderson Cancer Center Orlando. She received her medical degree from Duke University School of Medicine in Durham, North Carolina.
She did her residency and served as assistant chief resident in Internal Medicine at Duke University Medical Center. She completed her fellowship in Medical Oncology/Hematology at The University of Texas M. D. Anderson Cancer Center. Dr. Tseng is board certified in Internal Medicine and the specialty of Medical Oncology.
Dr. Tseng has received several awards and honors, which include the C.D. Howe Award for Clinical Excellence in Medical Oncology and a Clinical Research Award from The University of Texas M. D. Anderson Cancer Center; the American Medical Women's Award, Hewlett Packard Award, and the Alpha Omega Alpha Research Symposium Award from Duke University, and a Beneficial-Hodgson scholarship from Johns Hopkins University. In addition to her clinical studies, Dr. Tseng has published research on various topics including molecular alterations in lung cancer, gender differences in lung cancer, and novel agents in the treatment of head and neck cancer.
__________________________________________________________________
Radical Neck DissectionOK, let me bring you all the way up to date. Tomorrow, December 13, 2006, Dr. Shellenberger will do a Radical Neck Dissection. We are visiting him today to learn specifically what he plans to accomplish.
"A radical neck dissection is an operation used to remove cancerous tissue in the head and neck". "The purpose of radical neck dissection is to remove lymph nodes and other structures in the head and neck that are likely or proven to be malignant. Variations on neck dissections exist depending on the extent of the cancer. A radical neck dissection removes the most tissue. It is done when the cancer has spread widely in the neck. A modified neck dissection removes less tissue, and a selective neck dissection even less". (For more info, surgery details and recovery, see this web site:
http://www.healthatoz.com/healthatoz/Atoz/common/standard/transform.jsp?requestURI=/healthatoz/Atoz/ency/radical_neck_dissection.jsp )
I have three key areas of risk: 1) having to remove the carotid artery, 2) damage to the vagus nerve, and 3) overdosing radiation treatment. All three are high risk situations and are real concerns to Dr. Shellenberger.
Last week we simulated a complete acclussion to the carotid (cutting blood supply to the brain off completely by inflating a baloon inside the carotid just below the tumor location). The test went very well and I showed no sign of possible stroke. So this concern was greatly reduced this past week. Now we have the nerve damage and radiation issues to deal with. Hopefully, I'll be able to give you an update on these two areas after surgery!
"That's All Folks!"Well, I did it... updated my blog. I really thought I wouldn't have the time or patience to do it. But I'm glad I have the news posted for those that have been left in the dark. I really do appreciate the interest and support so many friends and family have shown. Thank-you!
Roy